For the past 50 years, the PhRMA Foundation has had the opportunity to support young scientists across numerous disciplines through grants and fellowships. In looking back through the years, and 2015 in particular, we asked past award recipients about the support they received. Here’s what some of them had to say:
- “Grants and fellowships such as the ones the PhRMA Foundation provides are critically important for the development of young scientists.” – Mark J. Ratain, M.D.
- “The PhRMA Foundation Post Doctoral Fellowship in Translational Medicine and Therapeutics has provided me with a wonderful opportunity to continue my current research and training on tumor immunogenomics. The award also encouraged me greatly by strengthening my confidence in the importance of my research. I am grateful to the PhRMA Foundation for all of this.” – Jing Sun, Ph.D.
- “The PhRMA Foundation Fellowship in Pharmacology/Toxicology has allowed me to explore neural systems within the brain that contribute to our understanding of neuropsychiatric disorders, to work toward clearer answers to the questions that continue to arise in the field, and to expand that body of knowledge for the improvement of medicine and human health.” – Nayna Sanathara
- “The PhRMA Foundation Pre Doctoral Fellowship has provided me with the financial resources to explore scientific hypotheses in the field of pharmacology/toxicology. In addition, this award was invaluable for other aspects of my graduate training, including grant writing and networking. I am extremely grateful for this opportunity.” – Robert N. Helsley
- “The PhRMA Foundation Research Starter Grant allowed me to pursue the translational studies that were the logical continuation of my research in animal models. The award gave me the opportunity to fund clinical studies that provided another dimension in my research.” – Georgios Paschos, Ph.D.
- “A Pharmacology/Toxicology Post Doctoral Fellowship from the PhRMA Foundation has provided me with a stable source of funding while conducting research on a novel class of pharmacotherapies with the potential to treat those suffering from neurodevelopmental disorders such as Autism Spectrum Disorder. It has given me the individual resources necessary to conduct this valuable work while at the same time affording me the opportunity to continue down the path of building a career as an independent research investigator.” – Matthew J. Robson, Ph.D.
Congratulations to all of our 2015 award recipients!
Learn more about the PhRMA Foundation in our 2015 Annual Report.
Eileen Cannon Eileen is president of the PhRMA Foundation.